Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The metabolic fingerprint of COVID-19 severity

View ORCID ProfileTim Dierckx, Jan van Elslande, Heli Salmela, Bram Decru, View ORCID ProfileEls Wauters, View ORCID ProfileJan Gunst, View ORCID ProfileYannick Van Herck, the CONTAGIOUS-consortium, View ORCID ProfileJoost Wauters, View ORCID ProfileBjörn Stessel, View ORCID ProfilePieter Vermeersch
doi: https://doi.org/10.1101/2020.11.09.20228221
Tim Dierckx
1KU Leuven, Department of Microbiology and immunology, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tim Dierckx
  • For correspondence: tim.dierckx@kuleuven.be
Jan van Elslande
2University Hospitals Leuven, Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heli Salmela
3Nightingale Health Ltd, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bram Decru
2University Hospitals Leuven, Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Els Wauters
4KU Leuven, Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium
5University Hospitals Leuven, Department of Pneumology, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Els Wauters
Jan Gunst
6KU Leuven, Department of Cellular and Molecular Medicine, Clinical Department and Laboratory of Intensive Care Medicine, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Gunst
Yannick Van Herck
7KU Leuven, Department of Oncology, Laboratory of Experimental Oncology, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yannick Van Herck
Joost Wauters
8University Hospitals Leuven, Medical Intensive Care Unit, Laboratory for Clinical Infectious and Inflammatory Diseases, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joost Wauters
Björn Stessel
9Jessa Hospital, Department of Anaesthesiology and Pain Medicine, Hasselt, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Björn Stessel
Pieter Vermeersch
2University Hospitals Leuven, Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pieter Vermeersch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Corona virus disease 2019 (COVID-19) has been associated with a wide range of divergent pathologies, and risk of severe disease is reported to be increased by a similarly broad range of co-morbidities. The present study investigated blood metabolites in order to elucidate how infection with severe acute respiratory syndrome coronavirus 2 can lead to such a variety of pathologies and what common ground they share. COVID-19 patient blood samples were taken at hospital admission in two Belgian patient cohorts, and a third cohort that included longitudinal samples was used for additional validation (total n=581). A total of 251 blood metabolite measures and ratios were assessed using nuclear magnetic resonance spectroscopy and tested for association to disease severity. In line with the varied effects of severe COVID-19, the range of severity-associated biomarkers was equally broad and included increased inflammatory markers (glycoprotein acetylation), amino acid concentrations (increased leucine and phenylalanine), increased lipoprotein particle concentrations (except those of very low density lipoprotein, VLDL), decreased cholesterol levels (except in large HDL and VLDL), increased triglyceride levels (only in IDL and LDL), fatty acid levels (decreased poly-unsaturated fatty acid, increased mono-unsaturated fatty acid) and decreased choline concentration, with association sizes comparable to those of routine clinical chemistry metrics of acute inflammation. Our results point to systemic metabolic biomarkers for COVID-19 severity that make strong targets for further fundamental research into its pathology (e.g. phenylalanine and omega-6 fatty acids).

Competing Interest Statement

HS is an employee of Nightingale Health Ltd.

Clinical Trial

NCT04327570

Funding Statement

TD is funded by a research grant by the Research Foundation Flanders (FWO Vlaanderen, 12Y6320N). PV is a senior clinical investigator of the FWO-Vlaanderen. JG holds a postdoctoral research fellowship supported by Clinical Research and Education Council of the University Hospitals Leuven.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Medical Ethical Committee of the University Hospitals of Leuven (MEC, UZ Leuven, s64161 and s63881) and the ethical approval committee of the Jessa hospital (20.75-20.05). Samples from UZL and Jessa cohorts were collected retrospectively, while the CONTAGIOUS cohort study is a prospective observational trial for which informed consent was obtained for all participants (clinicaltrials.gov identifier NCT04327570).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

For purposes of reproducing the results and additional research, data can be made available from the authors upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The metabolic fingerprint of COVID-19 severity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The metabolic fingerprint of COVID-19 severity
Tim Dierckx, Jan van Elslande, Heli Salmela, Bram Decru, Els Wauters, Jan Gunst, Yannick Van Herck, the CONTAGIOUS-consortium, Joost Wauters, Björn Stessel, Pieter Vermeersch
medRxiv 2020.11.09.20228221; doi: https://doi.org/10.1101/2020.11.09.20228221
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The metabolic fingerprint of COVID-19 severity
Tim Dierckx, Jan van Elslande, Heli Salmela, Bram Decru, Els Wauters, Jan Gunst, Yannick Van Herck, the CONTAGIOUS-consortium, Joost Wauters, Björn Stessel, Pieter Vermeersch
medRxiv 2020.11.09.20228221; doi: https://doi.org/10.1101/2020.11.09.20228221

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)